Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma
- PMID: 21998757
- PMCID: PMC3188713
- DOI: 10.3802/jgo.2011.22.3.152
Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma
Abstract
Objective: Concurrent chemoradiation has improved survival of patients with cervical carcinoma. However, follow-up of randomized studies is relatively short and data on long term toxicity are scarce, as is information on their health-related quality of life. This study assesses and compares incidences of late side-effects among patients treated with radiotherapy or chemoradiation using two toxicity scoring systems, and investigates impact on health-related quality of life.
Methods: Between 1985 and 1993, 114 patients underwent radiotherapy (n=39) or chemoradiation (n=75) for stage IIA-IVB cervical carcinoma. Late side-effects were scored retrospectively by reviewing medical charts using standardised checklists, focusing on bladder- and intestinal side effects. Health-related quality of life was assessed once using the EORTC QLQ-C30.
Results: No significant differences in late treatment-related side-effects between radiotherapy and chemoradiation groups were found. Grade ≥ 2 toxicity was found in 33% (bladder), and in 6% (bowel). Only 1.8% had both grade 3-4 toxicity. Bladder syndrome with high urinary frequency, urine incontinence and small bowel toxicity had a significant impact on health-related quality of life.
Conclusion: Grade 2 are relatively frequent late side effects in curatively treated patients, but are not enhanced by the addition of chemotherapy. Their negative impact on health-related quality of life stresses the importance of new radiation techniques, aiming at reduction of these side effects.
Keywords: Cervical carcinoma; Concurrent radiochemotherapy; Late treatment-related morbidity; Radiotherapy.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
References
-
- Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29:471–488. - PubMed
-
- Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 2003;68:217–226. - PubMed
-
- Denton AS, Bond SJ, Matthews S, Bentzen SM, Maher EJ UK Link Gynaecology-Oncology Group. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) 2000;12:347–353. - PubMed
-
- Lajer H, Thranov IR, Skovgaard LT, Engelholm SA. Late urologic morbidity in 177 consecutive patients after radiotherapy for cervical carcinoma: a longitudinal study. Int J Radiat Oncol Biol Phys. 2002;54:1356–1361. - PubMed
-
- National Cancer Institutes. Bethesda, MD: National Cancer Instututes; 2004. [cited 2011 Jun 20]. Guidelines gynaecologic tumours: cervical carcinoma [Internet] Available from: http://www.cancer.gov.
